Board of Directors
Lisa D. Earnhardt has served as President, CEO and as a member of our board of directors since 2008 and has led the company from the early clinical stage. Previously, Ms. Earnhardt was President of Boston Scientific’s Cardiac Surgery division. Ms. Earnhardt has over two decades of experience in healthcare, primarily in leading global product launches and driving adoption of new medical technologies at both Boston Scientific and Guidant.
Ms. Earnhardt also currently serves on the board of directors of Nevro Corporation (NYSE: NVRO). She previously served on the board of directors of Kensey Nash, a publicly traded company from 2011 until it was acquired by Royal DSM NA in 2012. Ms. Earnhardt serves on the board of directors of the Advanced Medical Technology Association (AdvaMed).
Terri Kline joined the Intersect ENT Board in August 2017. Kline is a leader in health care insurance, managed care, physician practice management, and outpatient facility management. As president and CEO of Health Alliance Plan (HAP), a Michigan-based nonprofit health plan providing coverage to nearly 700,000 members, Kline provides strategic, financial, and operational leadership for the organization and its five subsidiaries. She is also an executive vice president of Henry Ford Health System, which is comprised of hospitals, medical centers and one of the nation's largest group practices, the Henry Ford Medical Group.
Previously, Kline served as senior vice president and chief health care management officer for Health Care Service Corporation (HCSC), senior vice president of HealthSouth, CEO of United Healthcare of Georgia, and regional vice president of Aetna Health Plans.
Kline also serves on the board of directors of Presbyterian Health Plan in New Mexico. She holds a bachelor’s degree in biology from Kalamazoo College and a master of public health degree from the University of Michigan.
Kieran Gallahue joined our board of directors in April 2015 as Lead Director and also serves on the Audit Committee. Mr. Gallahue has 20 years of strategic, operational and corporate management experience in the healthcare industry, with deep expertise in the medical technologies field. He was Chairman and CEO at CareFusion (a publicly traded company acquired by Becton Dickinson in March 2015), from 2011 until March 2015. Previously, Mr. Gallahue was President, CEO and a Director of ResMed (NYSE: RMD), a medical device company serving the sleep disordered breathing and respiratory markets.
Mr. Gallahue also currently serves on the board of directors at Edwards Lifesciences (NYSE: EW), a global leader in the science of heart valves and hemodynamic monitoring. Mr. Gallahue served on the board of Volcano Corp., a developer of products for interventional cardiology. Mr. Gallahue previously served on the Executive Committee of the board of directors of the Advanced Medical Technology Association (AdvaMed).
Mr. Gallahue holds a bachelor’s degree in economics from Rutgers University and a master’s degree from Harvard Business School.
Dana G. Mead, Jr. joined our board of directors in June 2007. Since November 2016, Mr. Mead has served as President & CEO of Beaver-Visitec International (BVI), a medical device company located in Waltham, MA. Previously, Mr. Mead was a Strategic Advisor and a partner at Kleiner Perkins Caufield & Byers (KPCB) in the firm’s life sciences practice supporting innovative entrepreneurial startup companies. Before joining KPCB, Mr. Mead was President of Guidant Vascular Intervention. Mr. Mead joined Guidant in 1992 and held various management positions during his tenure.
Mr. Mead currently serves on the board of directors of Pulmonx, Inspire and ATI. Mr. Mead formerly served on the Board of Directors at Teladoc, Inc. (TDOC), a telehealth platform company, California Healthcare Institute, Lucile Packard Children’s Hospital at Stanford University and as a Director of the Cardiovascular Research Foundation, Aesthera (acquired by Solta), Corventis (acquired by Medtronic), Navigenics (acquired by Life Technologies Corp.), Invuity, Spinal Modulation (acquired by St. Jude Medical) and OtisMed (acquired by Stryker).
Mr. Mead received his B.A. from Lafayette College and holds an M.B.A. from the University of Southern California.
Frederic H. Moll, M.D. joined our board of directors in March 2006. Dr. Moll is Chairman and CEO of Auris Surgical Robotics, Inc. Prior to Auris, Dr. Moll co-founded Hansen Medical and served as the company’s first CEO. In 2002, Dr. Moll co-founded Restoration Robotics and has served as its Chairman since 2004. Dr. Moll founded Intuitive Surgical, Inc. also serving as the company’s first CEO, and co-founded Origin Medsystems, Inc., which later became an operating company within Guidant Corp. following its acquisition by Eli Lilly & Co. Dr. Moll served as medical director of Guidant’s surgical device division, and before that he founded Endotherapeutics Corp., a pioneering company in laparoscopic surgical technology.
Dr. Moll has authored numerous scientific articles and was previously a member of the board of directors of MAKO Surgical Corp. (acquired by Stryker) and of Hansen Medical, Inc., both publicly traded companies.
Dr. Moll holds a B.A. from the University of California, Berkeley, an M.S. from Stanford University and an M.D. from the University of Washington School Of Medicine.
Cynthia Lucchese joined our board of directors in July 2014. Ms. Lucchese is Chief Administrative Officer and CFO of Hulman & Company in Indianapolis, IN. Ms. Lucchese has over two decades of financial management experience in the healthcare industry and has held CFO positions at two publicly traded companies, Hillenbrand, Inc. (formerly Batesville Holdings, Inc.), and Thoratec Corp. Ms. Lucchese had also held several positions at Guidant including Corporate Vice President and Treasurer.
Ms. Lucchese currently serves on the board of directors at Hanger Orthopedics (NYSE: HNGR) and previously served on the board of directors of Brightpoint, Inc. from 2009 to 2012.
Ms. Lucchese is a Certified Public Accountant and received a B.S. with distinction in Accounting and an M.B.A. in Finance from the Indiana University Kelley School of Business.
Anthony Vernon joined our board of directors in April 2015. Mr. Vernon served as CEO for Kraft Foods Group, Inc. from 2012 to 2014, and as President of Kraft Foods North America and Executive Vice President of the former parent of Kraft Foods Group, Inc. from 2009 to 2012. Mr. Vernon was a member of the board of directors of Kraft Foods Group, Inc. until May 2015. Prior to joining Kraft, Mr. Vernon was the healthcare industry partner of Ripplewood Holdings LLC, a private equity firm. Prior to Ripplewood Holdings, Mr. Vernon held a variety of leadership positions during a 23-year career at Johnson & Johnson where he led a number of their largest franchises.
Mr. Vernon currently serves on the board of directors at The WhiteWave Foods Company (NASDAQ: WWAV), Medivation, Inc. (NASDAQ: MDVR) and NovoCure (NASDAQ: NVCR). Mr. Vernon previously served as a Director of Uluru, Inc. (NASDAQ: ULUR).
Mr. Vernon holds a bachelor's degree from Lawrence University in history and a M.B.A. from the Kellogg Graduate School of Management at Northwestern University.